REMI - Remedent, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue3/31/20173/31/20163/31/2015
Total Revenue2,355.7062,770.0923,616.355
Cost of Revenue1,170.544817.3911,280.406
Gross Profit1,185.1621,952.7012,335.949
Operating Expenses
Research Development8.4248.78161.246
Selling General and Administrative2,091.7571,778.2391,914.512
Non Recurring---
Others154.757158.463254.776
Total Operating Expenses---
Operating Income or Loss-1,069.7767.218105.415
Income from Continuing Operations
Total Other Income/Expenses Net1,591.699-9.44527.025
Earnings Before Interest and Taxes859.958263.17239.103
Interest Expense36.61263.44375.06
Income Before Tax823.346199.727164.043
Income Tax Expense-3.56422.93830.565
Minority Interest69.27486.73470.747
Net Income From Continuing Ops1,182.405426.199211.822
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income1,182.405426.199211.822
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares844.37160.802105.159